Literature DB >> 25303417

Rural populations have equal surgical and survival outcomes in metastatic colorectal cancer.

Apresh Singla1, Vy Broadbridge, Murthy Mittinty, Carol Beeke, Guy J Maddern.   

Abstract

OBJECTIVE: Previous Australian studies have suggested poorer survival of patients with colorectal cancer in remote areas. To date no studies have assessed the geographic disparity in patients with metastatic disease. This retrospective cohort study looks at geographic differences in the surgical care and survival of patients with metastatic colorectal disease. The paper utilises data from the South Australian Clinical Registry for Metastatic Colorectal Cancer (SACRMCC). DESIGN, PARTICIPANTS, INTERVENTIONS AND MAIN OUTCOME MEASURES: Data on patients' socio-economic status, primary and metastatic tumour characteristics, treatment and survival was extracted from the SACRMCC database. A binomial model analysis was used to identify geographical differences in the surgical treatment of patients and a Cox proportional hazards model was used to identify any geographic differences in survival.
RESULTS: The findings showed no differences in the diagnosis of liver metastases or provision of liver surgery between geographic areas, however there was a reduced likelihood of liver surgery with increasing age. The median overall survival rate, from the date of diagnosis of metastatic disease, was 20.0 months and the distribution by geographic remoteness was 19.1 months, 20.2 months, 22.0 months and 20.4 months in Major Cities, Inner Regional, Outer Regional and Remote areas respectively. This was not statistically significant.
CONCLUSION: Overall, there was no evidence of a geographical disparity in the diagnosis, surgical treatment or survival in metastatic colorectal cancer. This may be due to the shift toward centralising surgical care in South Australia. Nevertheless, there remains a need to improve the uptake of surgical care in the growing elderly population.
© 2014 National Rural Health Alliance Inc.

Entities:  

Keywords:  oncology; remote health; rural oncology; rurality; therapeutics

Mesh:

Year:  2014        PMID: 25303417     DOI: 10.1111/ajr.12133

Source DB:  PubMed          Journal:  Aust J Rural Health        ISSN: 1038-5282            Impact factor:   1.662


  6 in total

Review 1.  Is It Time to Centralize Ovarian Cancer Care in the United States?

Authors:  Renee A Cowan; Roisin E O'Cearbhaill; Ginger J Gardner; Douglas A Levine; Kara Long Roche; Yukio Sonoda; Oliver Zivanovic; William P Tew; Evis Sala; Yulia Lakhman; Hebert A Vargas Alvarez; Debra M Sarasohn; Svetlana Mironov; Nadeem R Abu-Rustum; Dennis S Chi
Journal:  Ann Surg Oncol       Date:  2015-10-28       Impact factor: 5.344

Review 2.  A systematic review of geographical differences in management and outcomes for colorectal cancer in Australia.

Authors:  Michael J Ireland; Sonja March; Fiona Crawford-Williams; Mandy Cassimatis; Joanne F Aitken; Melissa K Hyde; Suzanne K Chambers; Jiandong Sun; Jeff Dunn
Journal:  BMC Cancer       Date:  2017-02-02       Impact factor: 4.430

3.  Geographical Variations in the Clinical Management of Colorectal Cancer in Australia: A Systematic Review.

Authors:  Fiona Crawford-Williams; Sonja March; Michael J Ireland; Arlen Rowe; Belinda Goodwin; Melissa K Hyde; Suzanne K Chambers; Joanne F Aitken; Jeff Dunn
Journal:  Front Oncol       Date:  2018-05-16       Impact factor: 6.244

4.  A cross-sectional study to assess knowledge of women about cervical cancer: an urban and rural comparison.

Authors:  Małgorzata Lesińska-Sawicka
Journal:  Environ Health Prev Med       Date:  2021-06-07       Impact factor: 3.674

5.  Expression of Paxillin is Correlated with Clinical Prognosis in Colorectal Cancer Patients.

Authors:  Cheng-jin Zhao; Shuang-kuan Du; Xing-bo Dang; Min Gong
Journal:  Med Sci Monit       Date:  2015-07-10

6.  Sociodemographic disparities in survival from colorectal cancer in South Australia: a population-wide data linkage study.

Authors:  Kerri R Beckmann; Alice Bennett; Graeme P Young; Stephen R Cole; Rohit Joshi; Jacqui Adams; Nimit Singhal; Christos Karapetis; David Wattchow; David Roder
Journal:  BMC Health Serv Res       Date:  2016-01-20       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.